Evaxion announces closing of $10.8 million public offering
COPENHAGEN, Denmark, January 31, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”),…
Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement
Following a constructive Nasdaq hearing panel on January 7, 2025, Evaxion has…
DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu
CAMBRIDGE, England and SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- DIOSynVax, a…
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering
Jilin, China, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited…
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering
Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited…
Blue Lake Biotechnology Reports Additional Promising Clinical Data from Ongoing Pediatric Clinical Study of Intranasal RSV Vaccine BLB201
Company leaders to speak today during the open public hearing session of…
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
MALVERN, Pa., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or…
COVID Vaccines Genetic Mechanism Inadequately Tested, according to Journal of American Physicians and Surgeons (AAPS)
TUCSON, Ariz., Dec. 09, 2024 (GLOBE NEWSWIRE) -- The regulatory framework has…